Lupin launches generic Vigamox Ophthalmic solution in the US
Pharma major, Lupin Limited announced the launch of its Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5% (base) having received an approval from the USFDA earlier.
Lupin’s Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5% (base), is an AT1 rated generic equivalent of Novartis Pharma Corp’s Vigamox Ophthalmic solution. It is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the organisms.
Vigamox Ophthalmic solution had US sales of USD 267.9 million (IMS MAT March 2017). Lupin was trading in positive territory at Rs 1052.5 per share up by Rs 8.6 per share or 0.8%. It is outperforming the Nifty Pharma index on Wednesday.
Stock View :
Lupin Ltd is currently trading at Rs 1056.5, up by Rs 12.3 or 1.18% from its previous closing of Rs 1044.2 on the BSE.
The scrip opened at Rs 1050 and has touched a high and low of Rs 1057.9 and Rs 1036.8 respectively. So far 1665717(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 47169.01 crore.
The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 1750 on 29-Jul-2016 and a 52 week low of Rs 1040.3 on 04-Jul-2017. Last one week high and low of the scrip stood at Rs 1069.95 and Rs 1040.3 respectively.
The promoters holding in the company stood at 46.69 % while Institutions and Non-Institutions held 41.24 % and 12.06 % respectively.
The stock is currently trading below its 200 DMA.
Lupin’s Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5% (base), is an AT1 rated generic equivalent of Novartis Pharma Corp’s Vigamox Ophthalmic solution. It is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the organisms.
Vigamox Ophthalmic solution had US sales of USD 267.9 million (IMS MAT March 2017). Lupin was trading in positive territory at Rs 1052.5 per share up by Rs 8.6 per share or 0.8%. It is outperforming the Nifty Pharma index on Wednesday.
Stock View :
Lupin Ltd is currently trading at Rs 1056.5, up by Rs 12.3 or 1.18% from its previous closing of Rs 1044.2 on the BSE.
The scrip opened at Rs 1050 and has touched a high and low of Rs 1057.9 and Rs 1036.8 respectively. So far 1665717(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 47169.01 crore.
The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 1750 on 29-Jul-2016 and a 52 week low of Rs 1040.3 on 04-Jul-2017. Last one week high and low of the scrip stood at Rs 1069.95 and Rs 1040.3 respectively.
The promoters holding in the company stood at 46.69 % while Institutions and Non-Institutions held 41.24 % and 12.06 % respectively.
The stock is currently trading below its 200 DMA.
Lupin Ltd :-
BSE 1,055.05 10.85 (1.04%)
NSE 1,055.85 11.95 (1.14%)
Comments
Post a Comment